Herbs for Cognitive Enhancement: Pharmacological Insights into Memory and Neuroprotection

Abstract

Cognitive dysfunction and neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and age-related cognitive decline are growing public health concerns, with current treatments often providing limited efficacy and adverse effects. This review explores the potential of herbal medicine as a safer, multi-targeted approach to cognitive enhancement and neuroprotection, drawing from traditional systems like Ayurveda, Traditional Chinese Medicine, and Unani. A systematic literature review using databases such as PubMed, Scopus, and ScienceDirect identified key herbs including Bacopa monnieri, Ginkgo biloba, Withania somnifera, Centella asiatica, Curcuma longa, Salvia officinalis, and Panax ginseng with nootropic and neuroprotective properties. Phytochemicals such as bacosides, ginkgolides, and withanolides were found to modulate multiple pathways, including antioxidant defense, cholinesterase inhibition, neurotrophic support, anti-inflammatory activity, and mitochondrial protection. Both preclinical and clinical studies report cognitive benefits, such as enhanced memory, attention, and neuroplasticity, in healthy individuals and patients with cognitive impairment. While the findings support the therapeutic promise of these herbs, challenges remain in standardizing formulations, ensuring bioavailability, and gaining regulatory approval. Thus, further research should emphasize robust clinical trials and pharmacokinetic evaluations to validate the safety and efficacy of herbal agents as complementary or alternative options for managing cognitive decline and neurodegenerative disorders.

Introduction

Cognitive decline, ranging from mild cognitive impairment to severe neurodegenerative diseases like Alzheimer’s and Parkinson’s, is a growing global health concern, especially with an aging population. Conventional drugs often offer limited benefits and carry side effects, prompting interest in herbal medicines rooted in traditional systems like Ayurveda and Traditional Chinese Medicine. These herbs contain bioactive phytochemicals (alkaloids, flavonoids, terpenoids, phenolics) with antioxidant, anti-inflammatory, and neuroprotective effects that may help prevent or slow cognitive decline.

Mechanisms of Cognitive Impairment:
Cognitive decline involves oxidative stress, mitochondrial dysfunction, neuroinflammation, excitotoxicity, amyloid-beta accumulation, and cholinergic deficits. Herbs act by countering these processes through antioxidant activity, reducing inflammation, and modulating neurotransmitters.

Key Herbs and Their Effects:

• Bacopa monnieri (Brahmi): Antioxidant, improves memory, reduces amyloid plaques.

• Ginkgo biloba: Enhances cerebral blood flow, protects neurons, improves dementia symptoms.

• Withania somnifera (Ashwagandha): Antioxidant, stimulates neurogenesis, reduces stress.

• Centella asiatica (Gotu Kola): Promotes neurogenesis, enhances memory, modulates neurotransmitters.

• Panax ginseng: Modulates neurotransmitters, antioxidant, reduces fatigue.

• Rhodiola rosea: Adaptogen reducing stress and mental fatigue, neuroprotective.

• Curcuma longa (Turmeric): Anti-inflammatory, clears amyloid-beta, antioxidant.

Pharmacological Actions:
These herbs improve cognition by modulating neurotransmitters (acetylcholine, dopamine, serotonin), inhibiting acetylcholinesterase, scavenging reactive oxygen species, and promoting neuronal regeneration.

Clinical Evidence:
Studies support cognitive benefits of herbs like Bacopa, Ginkgo, and Ashwagandha in memory improvement and dementia symptom relief, though inconsistent trial designs limit definitive conclusions.

Challenges:
Key obstacles include lack of standardization in herbal preparations, poor bioavailability of some compounds (e.g., curcumin), and regulatory issues affecting quality control and clinical acceptance.

Conclusion

Herbal medicines, such as Bacopa monnieri, Ginkgo biloba, and Ashwagandha, offer significant potential as neurotherapeutics, with growing pharmacological evidence supporting their cognitive-enhancing and neuroprotective effects. These herbs have shown promise in improving memory, attention, and cognitive function in conditions like mild cognitive impairment and age-related decline. However, challenges such as standardization, bioavailability, and regulatory inconsistencies remain. Overcoming these hurdles through rigorous clinical validation and technological advancements, including nanotechnology and bioenhancers, is crucial for integrating these herbs into modern neuropharmacology. With proper validation, herbal remedies could become safe and effective treatments for cognitive support and neuroprotection.

References

[1] Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9(6):369–74. [2] Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytother Res. 2003;17(1):1–18. [3] Kennedy DO, Scholey AB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des. 2006;12(35):4613–23. [4] Prasad KN. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2016;14(6):641–63. [5] Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148–60. [6] Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1(1):a006189. [7] D\'Andrea G. Can anti-inflammatory compounds be useful in Alzheimer’s disease? Trends Pharmacol Sci. 2005;26(6): 293–8. [8] Aguiar S, Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313–26. [9] Peth-Nui T, Watanabe H, Phachonpai W, et al. Effects of Bacopa monnieri on cognitive function, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2012;18(8):707–13. [10] Kongkeaw C, Dilokthornsakul P, Thanarangsarit P, et al. Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri. J Ethnopharmacol. 2014;151(1):528–35. [11] Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl). 2001;156(4):481–4. [12] Calabrese C, Gregory WL, Leo M, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707–13. [13] Maclennan KM, Darlington CL, Smith PF. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol. 2002;72(1-2):1–9. [14] Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci. 2003;60(9):1779–92. [15] Mahadevan S, Park Y. Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. J Food Sci. 2008;73(1):R14–9. [16] Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55(11):1409–15. [17] Kaschel R. Ginkgo biloba: specificity of neuropsychological improvement–a selective review in search of differential effects. Hum Psychopharmacol. 2009;24(5):345–70. [18] Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14(1–2):34–45. [19] Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1093–105. [20] Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–62. [21] Gray NE, Zweig JA, Caruso M, et al. Centella asiatica modulates antioxidant and mitochondrial pathways and improves cognitive function in mice. J Ethnopharmacol. 2018;222:508–17. [22] Soumyanath A, Zhong YP, Gold SA, et al. Centella asiatica accelerates nerve regeneration upon oral administration and contains multiple active fractions increasing neurite elongation in-vitro. J Pharm Pharmacol. 2005;57(9):1221–9. [23] Wattanathorn J, Muchimapura S, Boosaba K, et al. Cognitive enhancing effect of Centella asiatica in healthy elderly volunteers: a randomized, double-blind, placebo-controlled trial. J Ethnopharmacol. 2008;116(2):325–32. [24] Rao SB, Chetana M, Uma Devi P. Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol Behav. 2005;86(4):449–57. [25] Reay JL, Kennedy DO, Scholey AB. Effects of Panax ginseng on cognition, mood and physical performance: a review. J Psychopharmacol. 2005;19(6): 647–59. [26] Kennedy DO, Scholey AB, Wesnes KA. Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers. Nutr Neurosci. 2001;4(4):295–310. [27] Rausch WD, Liu S, Gille G, et al. Neuroprotective effects of ginsenosides. Acta Neurobiol Exp (Wars). 2006;66(4):369–75. [28] Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav. 2003;75(3):687–700. [29] Panossian A, Wikman G. Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress—protective activity. Pharmaceuticals. 2010;3(1):188–224. [30] Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev. 2001;6(3):293–302. [31] Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000;7(2):85–9. [32] Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370–7. [33] Begum AN, Jones MR, Lim GP, et al. Curcumin structure–function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\'s disease. J Pharmacol Exp Ther. 2008;326(1):196–208. [34] Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Ann Indian Acad Neurol. 2008;11(1):13–9. [35] Dhakal S, Subramanian B, Dhakal R, et al. Mechanisms and therapeutic prospects of medicinal plant bioactives against neurodegeneration. Phytomed Plus. 2022;2(1):100184. [36] Uabundit N, Wattanathorn J, Mucimapura S, et al. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer’s disease model. J Ethnopharmacol. 2010;127(1):26–31. [37] Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine. 2005;12(4):305–17. [38] Kumar N, Abichandani LG, Thawani V, et al. Efficacy of standardized extract of Bacopa monnieri (Bacognize®) on cognitive functions of medical students: A six-week, randomized placebo-controlled trial. Evid Based Complement Alternat Med. 2016;2016:4103423. [39] Lyle N, Bhattacharyya D, Sur TK, et al. Antioxidant and cognitive enhancing effects of an Ayurvedic preparation in normal and amnesic rats. Phytother Res. 2009;23(1):128–31. [40] Calapai G, Crupi A, Firenzuoli F, et al. Overview of systematic reviews of the effectiveness of herbal medicine for cognitive disorders. Phytother Res. 2020;34(1):58–70. [41] Naghizadeh B, Mansouri MT, Ghorbanzadeh B. The role of natural compounds in neuroprotection and neurodegeneration. Curr Neuropharmacol. 2020;18(6):479–91. [42] Jayaprakasam B, Nair MG. Neuroprotective and cognitive enhancement potentials of natural products in Alzheimer\'s disease. Food Funct. 2020;11(6):4990–5007. [43] da Silva T, Magalhães de Souza FM, Figueiredo RC, et al. Natural products as a source for novel drugs in neurodegenerative diseases. Molecules. 2020;25(11):2563. [44] Fraser T, Tay MZ, Poo MM. Advancing herbal medicine through pharmacological and molecular validation. Cell. 2021;184(4):1063–1076. [45] Sarris J. Herbal medicines in the treatment of psychiatric disorders: a systematic review. Phytother Res. 2007;21(8):703–16. [46] Singh N, Bhalla M, Jager PD, et al. An overview on Ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):208–13. [47] Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8(5):401–9. [48] Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18. [49] Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. [50] Sharma RA, Steward WP, Gescher AJ. Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol. 2007;595:453–70. [51] Choudhury H, Pandey M, Hua CK, et al. An update on natural compounds in the remedy of Alzheimer’s disease. Curr Med Chem. 2020;27(29):5038–60. [52] Patel SS, Shah KA, Chitre AN, et al. Bioavailability of phytoconstituents: A review. J Ayurveda Integr Med. 2010;1(2):88–96. [53] Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, et al. IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry and Therapeutics. Sci Rep. 2018;8(1):4329. [54] Singh R, Kaur N, Kishore L. Neuroprotective herbs: a review. Int J Pharm Sci Rev Res. 2011;7(1):127–33.

Copyright

Copyright © 2025 Mohamed Afsal A, Syed Ali Fathima, Gowrishallini P, Dhivya G, Devi Sowndarya N, Suprraja S. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.